COX-2 and Alzheimer's disease: Potential roles in inflammation and neurodegeneration

Expert Opinion on Investigational Drugs

Volumn 8, Issue 10, 1999, Pages 1521-1536

  O'Banion, M K ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Cyclooxygenase; Inflammation; Neurodegeneration; Nonsteroidal anti inflammatory drugs; Prostaglandins

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; PROSTANOID; PROSTANOID RECEPTOR; ROFECOXIB; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; DRUG DESIGN; DRUG TARGETING; ENZYME INHIBITION; GASTROINTESTINAL SYMPTOM; GLIA CELL; HUMAN; INFLAMMATION; NERVE DEGENERATION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; TREATMENT PLANNING;

EID: 0032846525     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.8.10.1521     Document Type: Review

References (166)